{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:23:18Z","timestamp":1759134198754},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,12,5]],"date-time":"2010-12-05T00:00:00Z","timestamp":1291507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10787-010-0071-3","type":"journal-article","created":{"date-parts":[[2010,12,4]],"date-time":"2010-12-04T03:25:53Z","timestamp":1291433153000},"page":"69-73","source":"Crossref","is-referenced-by-count":15,"title":["Hughes syndrome (the antiphospholipid syndrome): a disease of our time"],"prefix":"10.1007","volume":"19","author":[{"given":"Graham R. V.","family":"Hughes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,5]]},"reference":[{"key":"71_CR1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/RHU.0b013e31818f38d4","volume":"14","author":"R Adamson","year":"2008","unstructured":"Adamson R, Sangle S, Kaul A, Hughes GRV, D\u2019Cruz DP (2008) Clinical improvement in antiphospholipid syndrome after rituximab therapy. J Clin Rheumatol 14:359\u2013360","journal-title":"J Clin Rheumatol"},{"key":"71_CR2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/intimm\/dxm052","volume":"7","author":"M Blank","year":"2007","unstructured":"Blank M, Zandman-Goddard G, Krause I et al (2007) The efficacy of specific IVIG antiidiotypical antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. Int Immunol 7:857\u2013865","journal-title":"Int Immunol"},{"issue":"101","key":"71_CR3","first-page":"9","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunological mechanisms and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46(101):9\u201327","journal-title":"Arthritis Rheum"},{"key":"71_CR4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1191\/0961203306lu2272rr","volume":"15","author":"R Cimaz","year":"2006","unstructured":"Cimaz R, Meroni L, Shoenfeld Y (2006) Epilepsy as part of systemic lupus erythematousus and systemic antiphospholipid syndrome (Hughes Syndrome). Lupus 15:191\u2013194","journal-title":"Lupus"},{"key":"71_CR5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1191\/096120301678646119","volume":"10","author":"MJ Cuadrado","year":"2001","unstructured":"Cuadrado MJ, Khamashta MA, Hughes GRV (2001) Sticky blood and headache. Lupus 10:392\u2013393","journal-title":"Lupus"},{"key":"71_CR6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005792-200001000-00006","volume":"79","author":"MJ Cuadrado","year":"2002","unstructured":"Cuadrado MJ, Khamashta MA, Ballesteros A et al (2002) Can Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Medicine (Baltimore) 79:57\u201368","journal-title":"Medicine (Baltimore)"},{"key":"71_CR7","first-page":"652","volume":"22","author":"MJ Cuadrado","year":"2004","unstructured":"Cuadrado MJ, Wakefield K, Sanna G, Khamashta MA, Hughes GRV (2004) Multiple sclerosis in the antiphospholipid (Hughes) syndrome. A common differential diagnosis? Clin Exp Rheumatol 22:652\u2013653","journal-title":"Clin Exp Rheumatol"},{"key":"71_CR8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/art.20105","volume":"50","author":"RH Derksen","year":"2004","unstructured":"Derksen RH, Khamashta MA, Branch DW (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50:1028\u20131039","journal-title":"Arthritis Rheum"},{"key":"71_CR9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/096120339700600701","volume":"6","author":"J George","year":"1987","unstructured":"George J, Shoenfeld Y (1987) The antiphospholipid (Hughes) syndrome: a cross-roads of autoimmunity and atherosclerosis. Lupus 6:559\u2013560","journal-title":"Lupus"},{"key":"71_CR10","first-page":"613","volume":"132","author":"T Greco","year":"2009","unstructured":"Greco T, Conti-Kelly AH, Greco T Jr et al (2009) Newer antiphospholipid antibodies predict adverse outcomes in patients with acute coronary syndrome. Coagul Transfus Med 132:613\u2013620","journal-title":"Coagul Transfus Med"},{"key":"71_CR11","doi-asserted-by":"crossref","unstructured":"Harris EN, Gharavi, AE Boey ML, Patel BM, Mackworth-Young CG. Hughes GRV (1983) Anticardiolipin antibodies: detection by radioimmuno-assay and association with thrombosis in SLE. Lancet 2:1211\u20131214","DOI":"10.1016\/S0140-6736(83)91267-9"},{"key":"71_CR12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","volume":"287","author":"GRV Hughes","year":"1983","unstructured":"Hughes GRV (1983) Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J 287:1088\u20131089","journal-title":"Br Med J"},{"key":"71_CR13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/096120339800700201","volume":"7","author":"GRV Hughes","year":"1988","unstructured":"Hughes GRV (1988) Hughes Syndrome: the antiphospholipid syndrome\u2014a historical view. Lupus 7:S1\u2013S4","journal-title":"Lupus"},{"key":"71_CR14","doi-asserted-by":"crossref","unstructured":"Hughes GRV (2003) Migraine, memory loss and \u201cmultiple sclerosis\u201d. Neurological features of the antiphospholipid (Hughes) syndrome. Postgrad Med J 79:81\u20133","DOI":"10.1136\/pmj.79.928.81"},{"key":"71_CR15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/0961203309358186","volume":"19","author":"GRV Hughes","year":"2010","unstructured":"Hughes GRV (2010a) Antiphospholipid syndrome, migraine and stroke. Lupus 19:555\u2013556","journal-title":"Lupus"},{"key":"71_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/pmj.79.928.81","volume":"79","author":"GRV Hughes","year":"2010","unstructured":"Hughes GRV (2010b) Hughes Syndrome (antiphospholipid syndrome) and myocardial infarction. Postgrad Med J 79:81\u201383","journal-title":"Postgrad Med J"},{"key":"71_CR17","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1742-1241.2010.02340.x","volume":"64","author":"GRV Hughes","year":"2010","unstructured":"Hughes GRV (2010c) Hughes Syndrome (the antiphospholipid syndrome). Ten clinical lessons. Lupus 1988, 343\u2013346. Int J Clin Pract 64:1183\u20131184","journal-title":"Int J Clin Pract"},{"key":"71_CR18","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/ard.2003.006163","volume":"62","author":"GRV Hughes","year":"2003","unstructured":"Hughes GRV, Khamashta MA (2003) Sero-negative antiphospholipid syndrome. Ann Rheum Dis 62:1127","journal-title":"Ann Rheum Dis"},{"key":"71_CR19","first-page":"897","volume":"30","author":"E Letellier","year":"2003","unstructured":"Letellier E, Hughes GRV (2003) \u201cListen to the patient\u201d\u2014anticoagulation is critical in the antiphospholipid (Hughes) syndrome. J Rheumatol 30:897","journal-title":"J Rheumatol"},{"key":"71_CR20","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/j.1538-7836.2007.02763.x","volume":"5","author":"PL Meroni","year":"2007","unstructured":"Meroni PL, Peyvandi F, Foco L (2007) Anti-Beta 2 glycoprotein antibodies and the risk of myocardial infarction in young pre-menopausal women. J Thromb Haemost 5:2421\u20132428","journal-title":"J Thromb Haemost"},{"key":"71_CR21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1191\/0961203302lu210xx","volume":"11","author":"S Nair","year":"2002","unstructured":"Nair S, Khamashta MA, Hughes GRV (2002) Syndrome X and Hughes Syndrome. Lupus 11:332","journal-title":"Lupus"},{"key":"71_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.STR.23.2.189","volume":"23","author":"P Nencini","year":"1992","unstructured":"Nencini P, Baruffi MC, Abbate R et al (1992) Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischaemia. Stroke 23:189\u2013192","journal-title":"Stroke"},{"key":"71_CR23","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard.62.10.999","volume":"62","author":"S Sangle","year":"2003","unstructured":"Sangle S, D\u2019Cruz DP, Jan W (2003) Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis 62:999\u20131002","journal-title":"Ann Rheum Dis"},{"key":"71_CR24","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/ard.2003.016105","volume":"63","author":"S Sangle","year":"2004","unstructured":"Sangle S, D\u2019Cruz D, Khamashta MA, Hughes GRV (2004) Antiphospholipid antibodies, SLE and non-traumatic metatarsal fractures. Ann Rheum Dis 63:1241\u20131243","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"71_CR25","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","volume":"8","author":"R Urbanus","year":"2009","unstructured":"Urbanus R, Siegerink B, Roest M et al (2009) Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the ratio study. Lancet (Neurology) 8(11):998\u20131005","journal-title":"Lancet (Neurology)"},{"key":"71_CR26","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/rheumatology\/keq021","volume":"49","author":"PM Vaitla","year":"2010","unstructured":"Vaitla PM, McDermott EM (2010) The role of high-dose intravenous immunoglobulin in rheumatology. Rheumatology 49:1040\u20131048","journal-title":"Rheumatology"},{"key":"71_CR27","doi-asserted-by":"crossref","unstructured":"Ziakis PD, Pavlou M, Vougarelis M (2010) Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss. Obstet Gynaecol 115:1256\u20131262","DOI":"10.1097\/AOG.0b013e3181deba40"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-010-0071-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-010-0071-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-010-0071-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T16:25:35Z","timestamp":1559838335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-010-0071-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,5]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["71"],"URL":"https:\/\/doi.org\/10.1007\/s10787-010-0071-3","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,5]]}}}